Publications Library

Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxia.

A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression.

Fes Tyrosine Kinase Expression in the Tumor Niche Correlates with Enhanced Tumor Growth, Angiogenesis, Circulating Tumor Cells, Metastasis, and Infiltrating Macrophages

Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo.

Endothelial Growth Factor Receptor

Vascular Normalization by Loss of Siah2 Results in Increased Chemotherapeutic Efficacy

A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment.

Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors.

Quantitative ultrasound characterization of responses to radiotherapy in cancer mouse models.

Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model.